Furthermore, to confirm whether SERPINB2 can mediate the tumorigenic potential of various types of CSCs, we knocked down SERPINB2 expression using a specific shRNA in breast, colorectal and liver cancer cells (Figure 7A–D). The gene discussed is SERPINB2; the disease is liver cancer.